Meeting
2021 ASCO Annual Meeting
Gene expression associated with lymphovascular invasion and genomic risk in early-stage breast cancer.
Authors
Nina D'Abreo
Perlmutter Cancer Center at NYU Langone Hospital-Long Island, NYU Long Island School of Medicine, Mineola, NY
Nina D'Abreo , Abhinav Rohatgi , Douglas Kanter Marks , Heather Kling , Josien Haan , William Audeh
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Breast Cancer—Local/Regional/Adjuvant
Track
Breast Cancer
Sub Track
Biologic Correlates
Clinical Trial Registration Number
NCT03053193
Citation
J Clin Oncol 39, 2021 (suppl 15; abstr 559)
DOI
10.1200/JCO.2021.39.15_suppl.559
Abstract #
559
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Defining transcriptomic profiles of early-stage mucinous breast cancers: A FLEX sub study.
First Author: Abirami Sivapiragasam
Poster
2023 ASCO Annual Meeting
FLEX, a real-world evidence full transcriptome study of 30,000 patients with early-stage breast cancer.
First Author: Eric Allen Brown
Poster
2022 ASCO Annual Meeting
FLEX, the 30,000 breast cancer transcriptome project: A platform for early breast cancer research using full-genome arrays paired with clinical data.
First Author: Cynthia X. Ma
Poster
2022 ASCO Annual Meeting
Identification of transcriptional changes with MammaPrint and BluePrint in early-stage breast cancer after neoadjuvant chemotherapy.
First Author: Alice P. Chung